DALLA SEROTONINA E DOPAMINA ALLA TERAPIA DELL’OBESITÀ
https://doi.org/10.4081/incontri.2018.359
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Following development of pharmacological science in the last three decades, we started with brain studies aimed to characterize the role of serotonin and dopamine systems in feeding behaviour, by using traditional pharmacological approaches, such as injection of stimulatory and/or inhibitory drugs and monitoring the consequent behavioral changes. Then, we tried more physiological approaches to study serotonin system, by modulating its effects through special diets, thus proposing a new concept in nutritional pharmacology, in particular in the treatment of feeding disorders. Then, we focused to the study of obesity, by highlighting the multi-factorial approaches that, in addition to drugs, require an integration of other biological and psychological dimension, such as life style changes and cultural education, in treatment of this and related disorders.